| Adjustments* | Adjustments* | ||||||
| Adjusted* | (note 1) | Total | Adjusted* | (note 1) | Total | ||
| Notes | £m | £m | £m | £m | £m | £m | |
| Continuing operations | |||||||
Revenue | 1 | ||||||
Operating profit | ( | ( | |||||
Share of profit/(loss) of associate | 14 | ( | ( | ( | |||
(Loss)/profit on disposal of operations | 30 | ( | ( | ||||
Profit before interest and taxation | ( | ( | |||||
Finance income | 4 | ||||||
Finance expense | 5 | ( | ( | ( | ( | ||
Profit before taxation | 6 | ( | ( | ||||
Taxation | 9 | ( | ( | ( | ( | ||
Profit for the year | 1 | ( | ( | ||||
| Attributable to: | |||||||
Owners of the parent | |||||||
Non–controlling interests | |||||||
Earnings per share | 2 | ||||||
| From continuing operations | |||||||
Basic | |||||||
Diluted | |||||||
Dividends in respect of the year | 10 | ||||||
Paid and proposed (£m) | |||||||
Paid and proposed per share |
| Year ended | Year ended | ||
| 31 March | 31 March | ||
| 2026 | 2025 | ||
| Notes | £m | £m | |
Profit for the year | |||
| Items that will not be reclassified subsequently to the Consolidated Income Statement: | |||
Actuarial losses on defined benefit pension plans | 29 | ( | |
Tax relating to components of other comprehensive income that will not be reclassified | 9 | ||
Unrealised losses in the fair value of equity investments at fair value through other comprehensive income | 14 | ( | ( |
| Items that may be reclassified subsequently to the Consolidated Income Statement: | |||
Effective portion of gains in fair value of cash flow hedges | 27 | ( | |
Deferred tax in respect of cash flow hedges accounted for in the hedging reserve | 9 | ( | |
Exchange gain/(loss) on translation of foreign operations and net investment hedge | ( | ||
Exchange gain on translation of foreign operations recycled to income statement on disposal | 30 | ( | ( |
Other comprehensive expense for the year | ( | ( | |
Total comprehensive income for the year | |||
| Attributable to: | |||
Owners of the parent | |||
Non‑controlling interests |
| 31 March | |||
| 2025 | |||
| Notes | £m | £m | |
| Non‑current assets | |||
Goodwill | 11 | ||
Other intangible assets | 12 | ||
Property, plant and equipment | 13 | ||
Interest in associates and other investments | 14 | ||
Retirement benefit asset | 29 | ||
Deferred tax assets | 22 | ||
| Current assets | |||
Inventories | 15 | ||
Trade and other receivables | 16 | ||
Tax receivable | |||
Cash and bank balances | |||
Derivative financial instruments | 27 | ||
Assets held for sale | 32 | ||
Total assets | |||
| Current liabilities | |||
Trade and other payables | 17 | ||
Borrowings | 19 | ||
Lease liabilities | 28 | ||
Provisions | 21 | ||
Tax liabilities | |||
Derivative financial instruments | 27 | ||
Liabilities held for sale | 32 | ||
Net current assets | |||
| Non‑current liabilities | |||
Borrowings | 19 | ||
Lease liabilities | 28 | ||
Retirement benefit obligations | 29 | ||
Trade and other payables | 20 | ||
Provisions | 21 | ||
Deferred tax liabilities | 22 | ||
Total liabilities | |||
Net assets | |||
| Equity | |||
Share capital | 23 | ||
Share premium account | |||
Own shares | ( | ( | |
Capital redemption reserve | |||
Hedging reserve | ( | ||
Translation reserve | |||
Other reserves | ( | ||
Retained earnings | |||
Equity attributable to owners of the parent | |||
Non‑controlling interests | |||
Total equity |
| Share | Capital | Non‑ | ||||||||
| Share | premium | Own | redemption | Hedging | Translation | Other | Retained | controlling | ||
| capital | account | shares | reserve | reserve | reserve | reserves | earnings | interest | Total | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At | ( | |||||||||
Profit for the year | ||||||||||
Other comprehensive expense | ( | ( | ( | ( | ||||||
| Total comprehensive income | ||||||||||
and expense | ( | ( | ( | |||||||
Dividends paid | ( | ( | ||||||||
Share‑based payment charge | ||||||||||
| Deferred tax on share‑based | ||||||||||
payment transactions | ||||||||||
| Excess tax deductions related | ||||||||||
to share‑based payments on vested awards | ||||||||||
Purchase of own shares | ( | ( | ( | |||||||
| Performance share plan | ||||||||||
awards vested | ( | ( | ||||||||
At | ( | ( | ( |
| Share | Capital | Non‑ | ||||||||
| Share | premium | Own | redemption | Hedging | Translation | Other | Retained | controlling | ||
| capital | account | shares | reserve | reserve | reserve | reserves | earnings | interest | Total | |
| £m | £m | £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 April 2024 | ( | ( | ||||||||
Profit for the year | ||||||||||
| Other comprehensive income | ||||||||||
and expense | ( | ( | ( | ( | ||||||
| Total comprehensive income | ||||||||||
and expense | ( | ( | ||||||||
Dividends paid | ( | ( | ||||||||
Share‑based payment charge | ||||||||||
| Deferred tax on share‑based | ||||||||||
payment transactions | ||||||||||
| Excess tax deductions related | ||||||||||
to share‑based payments on vested awards | ||||||||||
Purchase of own shares | ( | ( | ( | |||||||
| Performance share plan | ||||||||||
awards vested | ( | ( | ||||||||
Transfer of loss on disposal of equity investments at fair value through other comprehensive income to retained earnings | ( | |||||||||
At 31 March 2025 | ( |
| 31 March | 31 March | ||
| 2026 | 2025 | ||
| Notes | £m | £m | |
Net cash inflow from operating activities | 26 | ||
| Cash flows from investing activities | |||
Purchase of property, plant and equipment – owned assets | 13 | ( | ( |
Purchase of computer software | 12 | ( | ( |
Purchase of other intangibles | 12 | ( | ( |
Proceeds from sale of property, plant and equipment and capitalised development costs | |||
Development costs capitalised | 12 | ( | ( |
Interest received | |||
Acquisition of businesses, net of cash acquired | 25 | ( | ( |
Disposal of business, net of cash disposed | 30 | ||
Purchase of equity investments and associates | 14 | ( | |
Net cash used in investing activities | ( | ( | |
| Cash flows from financing activities | |||
Dividends paid | ( | ( | |
Purchase of shares for settlement of employee share arrangements | ( | ( | |
Interest paid | ( | ( | |
Loan arrangement fees | ( | ||
Proceeds from bank borrowings | 26 | ||
Repayment of bank borrowings | 26 | ( | ( |
Repayment of acquired debt on acquisition | 26 | ( | ( |
(Repayment)/drawdown of loan notes | 26 | ( | |
Repayment of lease liabilities, net of interest | ( | ( | |
Net cash used in financing activities | ( | ( | |
(Decrease)/increase in cash and cash equivalents | 26 | ( | |
Cash and cash equivalents brought forward | |||
Exchange adjustments | ( | ||
Cash and cash equivalents carried forward | 26 |
Freehold property | 2% |
Leasehold buildings and improvements | Shorter of 2% or period of lease |
Plant, equipment and vehicles | 8% to 33.3% |
| Year ended 31 March 2026 | |||||||
| Revenue by sector and destination (all continuing operations) | |||||||
| Africa, | |||||||
| United States | Mainland | United | Near and | Other | |||
| of America | Europe | Kingdom | Asia Pacific | Middle East | countries | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
Safety | 222.5 | 297.6 | 185.2 | 159.2 | 53.8 | 29.2 | 947.5 |
Environmental & Analysis | 700.9 | 96.4 | 104.1 | 105.4 | 12.9 | 18.0 | 1,037.7 |
Healthcare | 313.7 | 106.2 | 56.7 | 68.5 | 19.5 | 33.8 | 598.4 |
Inter‑segmental sales | – | – | (1.3) | – | – | – | (1.3) |
Revenue for the year | 1,237.1 | 500.2 | 344.7 | 333.1 | 86.2 | 81.0 | 2,582.3 |
| Year ended 31 March 2025 | |||||||
| Revenue by sector and destination (all continuing operations) | |||||||
| Africa, | |||||||
| United States | Mainland | United | Near and | Other | |||
| of America | Europe | Kingdom | Asia Pacific | Middle East | countries | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
Safety | 242.6 | 260.3 | 173.1 | 143.1 | 47.8 | 35.1 | 902.0 |
Environmental & Analysis | 492.1 | 70.6 | 93.6 | 86.2 | 17.1 | 17.0 | 776.6 |
Healthcare | 303.9 | 100.3 | 50.0 | 74.7 | 15.4 | 26.1 | 570.4 |
Inter‑segmental sales | – | – | (0.9) | – | – | – | (0.9) |
Revenue for the year | 1,038.6 | 431.2 | 315.8 | 304.0 | 80.3 | 78.2 | 2,248.1 |
| Year ended 31 March 2026 | |||
| Revenue | |||
| Revenue | recognised | ||
| recognised | at a point | Total | |
| over time | in time | Revenue | |
| £m | £m | £m | |
Safety | 16.7 | 930.8 | 947.5 |
Environmental & Analysis | 553.6 | 484.1 | 1,037.7 |
Healthcare | 82.8 | 515.6 | 598.4 |
Inter‑segmental sales | – | (1.3) | (1.3) |
Revenue for the year | 653.1 | 1,929.2 | 2,582.3 |
| Year ended 31 March 2025 | |||
| Revenue | |||
| Revenue | recognised | ||
| recognised | at a point | Total | |
| over time* | in time* | Revenue | |
| £m | £m | £m | |
Safety | 10.7 | 891.3 | 902.0 |
Environmental & Analysis | 320.4 | 456.2 | 776.6 |
Healthcare | 80.3 | 490.1 | 570.4 |
Inter‑segmental sales | – | (0.9) | (0.9) |
Revenue for the year | 411.4 | 1,836.7 | 2,248.1 |
| Year ended 31 March 2026 | ||||
| Revenue from | Revenue from | |||
| performance | Revenue | performance | ||
| obligations | previously | obligations | ||
| entered into | included as | satisfied in | ||
| and satisfied | contract | previous | Total | |
| in the year | liabilities | periods | Revenue | |
| £m | £m | £m | £m | |
Safety | 938.8 | 8.7 | – | 947.5 |
Environmental & Analysis | 1,029.7 | 8.0 | – | 1,037.7 |
Healthcare | 574.1 | 24.3 | – | 598.4 |
Inter‑segmental sales | (1.3) | – | – | (1.3) |
Revenue for the year | 2,541.3 | 41.0 | – | 2,582.3 |
| Year ended 31 March 2025 | ||||
| Revenue from | Revenue from | |||
| performance | Revenue | performance | ||
| obligations | previously | obligations | ||
| entered into | included as | satisfied in | ||
| and satisfied | contract | previous | Total | |
| in the year | liabilities | periods | Revenue | |
| £m | £m | £m | £m | |
Safety | 895.8 | 6.2 | – | 902.0 |
Environmental & Analysis | 768.9 | 7.7 | – | 776.6 |
Healthcare | 552.6 | 17.8 | – | 570.4 |
Inter‑segmental sales | (0.9) | – | – | (0.9) |
Revenue for the year | 2,216.4 | 31.7 | – | 2,248.1 |
| Aggregate transaction price allocated | ||||
| to unsatisfied performance obligations | ||||
| 31 March | To be | To be | To be | |
| 2026 | recognised | recognised | recognised | |
| Total | < 1 year | 1‑2 years | > 2 years | |
| £m | £m | £m | £m | |
Safety | 15.1 | 9.2 | 3.6 | 2.3 |
Environmental & Analysis | 30.1 | 15.6 | 4.9 | 9.6 |
Healthcare | 21.3 | 20.8 | 0.5 | – |
Inter‑segmental sales | – | – | – | – |
Total | 66.5 | 45.6 | 9.0 | 11.9 |
| Aggregate transaction price allocated | ||||
| to unsatisfied performance obligations | ||||
| 31 March | To be | To be | To be | |
| 2025 | recognised | recognised | recognised | |
| Total | < 1 year | 1‑2 years | > 2 years | |
| £m | £m | £m | £m | |
Safety | 18.2 | 10.0 | 3.5 | 4.7 |
Environmental & Analysis | 23.0 | 11.9 | 4.2 | 6.9 |
Healthcare | 28.1 | 27.3 | 0.8 | – |
Inter‑segmental sales | – | – | – | – |
Total | 69.3 | 49.2 | 8.5 | 11.6 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Segment profit before allocation of adjustments (Sector adjusted profit)* | ||
Safety | 253.6 | 217.9 |
Environmental & Analysis | 250.6 | 185.5 |
Healthcare | 143.1 | 130.6 |
647.3 | 534.0 | |
| Segment profit after allocation of adjustments* | ||
Safety | 219.2 | 192.1 |
Environmental & Analysis | 233.0 | 174.8 |
Healthcare | 121.3 | 92.0 |
Segment profit | 573.5 | 458.9 |
Central administration costs | (52.8) | (47.7) |
Group profit before interest and taxation | 520.7 | 411.2 |
Net finance expense | (30.0) | (26.9) |
Group profit before taxation | 490.7 | 384.3 |
Taxation | (118.4) | (87.9) |
Profit for the year | 372.3 | 296.4 |
| Year ended 31 March 2026 | |||||||
| Acquisition items | |||||||
| Total | |||||||
| Amortisation of | Release of | amortisation | |||||
| acquired | Adjustments | fair value | charge and | Disposal of | |||
| intangible | Transaction | to contingent | adjustments | acquisition | operations | ||
| assets | costs | consideration | to inventory | items | (note 30) | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
Safety | (24.2) | (3.0) | 0.3 | (2.4) | (29.3) | (5.1) | (34.4) |
Environmental & Analysis | (16.0) | (1.6) | 1.4 | (0.5) | (16.7) | (0.9) | (17.6) |
Healthcare | (23.0) | 0.6 | 1.1 | (0.3) | (21.6) | (0.2) | (21.8) |
Total Segment & Group | (63.2) | (4.0) | 2.8 | (3.2) | (67.6) | (6.2) | (73.8) |
| Year ended 31 March 2025 | |||||||
| Acquisition items | |||||||
| Total | |||||||
| Release of | amortisation | Disposal of | |||||
| Amortisation of | Adjustments | fair value | charge and | operations and | |||
| acquired | Transaction | to contingent | adjustments | acquisition | impairment | ||
| intangible assets | costs | consideration | to inventory | items | of associates | Total | |
| £m | £m | £m | £m | £m | £m | £m | |
Safety | (21.7) | (2.2) | – | (1.9) | (25.8) | – | (25.8) |
Environmental & Analysis | (12.9) | (0.5) | 0.8 | (0.1) | (12.7) | 2.0 | (10.7) |
Healthcare | (22.3) | (5.6) | (6.1) | (4.6) | (38.6) | – | (38.6) |
Total Segment & Group | (56.9) | (8.3) | (5.3) | (6.6) | (77.1) | 2.0 | (75.1) |
Assets | Liabilities | |||
| 31 March | 31 March | 31 March | 31 March | |
| Before goodwill, interest in associates and other investments and acquired intangible assets | 2026 | 2025 | 2026 | 2025 |
| are allocated to specific segment assets/liabilities | £m | £m | £m | £m |
Safety | 428.6 | 377.5 | 132.0 | 125.7 |
Environmental & Analysis | 361.2 | 285.4 | 144.9 | 108.3 |
Healthcare | 278.0 | 258.4 | 87.7 | 90.6 |
| Total segment assets/liabilities excluding goodwill, interest in associates | ||||
and other investments and acquired intangible assets | 1,067.8 | 921.3 | 364.6 | 324.6 |
Goodwill | 1,509.0 | 1,263.3 | – | – |
Acquired intangible assets | 684.7 | 518.4 | – | – |
Interest in associate and other investments | 21.4 | 12.5 | – | – |
| Total segment assets/liabilities including goodwill, interest in associates | ||||
and other investments and acquired intangible assets | 3,282.9 | 2,715.5 | 364.6 | 324.6 |
Assets | Liabilities | |||
| 31 March | 31 March | 31 March | 31 March | |
| After goodwill, interest in associates and other investments and acquired intangible assets | 2026 | 2025 | 2026 | 2025 |
| are allocated to specific segment assets/liabilities | £m | £m | £m | £m |
Safety | 1,345.8 | 1,005.8 | 132.0 | 125.7 |
Environmental & Analysis | 865.4 | 667.3 | 144.9 | 108.3 |
Healthcare | 1,071.7 | 1,042.4 | 87.7 | 90.6 |
| Total segment assets/liabilities including goodwill, interest in associates | ||||
and other investments and acquired intangible assets | 3,282.9 | 2,715.5 | 364.6 | 324.6 |
Cash and bank balances/borrowings | 143.4 | 313.2 | 805.6 | 739.4 |
Derivative financial instruments | 0.9 | 1.1 | 1.2 | 0.8 |
Other unallocated assets/liabilities | 263.5 | 228.8 | 369.2 | 294.4 |
Assets and liabilities held for sale (note 32) | 22.0 | – | 4.1 | – |
Total Group | 3,712.7 | 3,258.6 | 1,544.7 | 1,359.2 |
| Depreciation, | ||||
| Additions to | amortisation | |||
| non‑current assets | and impairment | |||
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | £m | £m | |
Safety | 334.3 | 111.9 | 39.3 | 37.2 |
Environmental & Analysis | 161.8 | 38.5 | 25.4 | 21.8 |
Healthcare | 44.8 | 54.7 | 32.8 | 33.4 |
Total Segment additions/depreciation, amortisation and impairment | 540.9 | 205.1 | 97.5 | 92.4 |
Unallocated | 45.7 | 67.9 | 32.7 | 32.0 |
Total Group | 586.6 | 273.0 | 130.2 | 124.4 |
| Non‑current assets | ||
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
United States of America | 844.8 | 900.5 |
Mainland Europe | 901.4 | 671.0 |
United Kingdom | 653.1 | 377.5 |
Asia Pacific | 127.0 | 124.2 |
Other countries | 59.5 | 61.8 |
2,585.8 | 2,135.0 |
| Per share | ||||
| Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | pence | pence | |
Earnings from continuing operations attributable to owners of the parent | 372.3 | 296.4 | 98.57 | 78.49 |
Amortisation and impairment of acquired intangible assets (after tax) | 49.2 | 42.9 | 13.03 | 11.39 |
Acquisition transaction costs (after tax) | 3.5 | 8.2 | 0.93 | 2.16 |
Adjustments to contingent consideration (after tax) | (2.8) | 5.3 | (0.74) | 1.39 |
Release of fair value adjustments to inventory (after tax) | 2.4 | 5.0 | 0.64 | 1.33 |
Impairment of associates (after tax) | – | 1.0 | – | 0.26 |
Disposal of operations (after tax) | 6.1 | (3.0) | 1.62 | (0.79) |
Adjusted earnings attributable to owners of the parent | 430.7 | 355.8 | 114.05 | 94.23 |
| Weighted average number of shares in issue for basic earnings | ||||
per share, million | 377.7 | 377.6 |
| Per share | ||||
| Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | pence | pence | |
Earnings from continuing operations attributable to owners of the parent | 372.3 | 296.4 | 98.17 | 78.14 |
Weighted average number of shares in issue for basic earnings per share, million | 377.7 | 377.6 | ||
Dilutive potential shares – share awards, million | 1.5 | 1.6 | ||
| Weighted average number of shares in issue for diluted | ||||
earnings per share, million | 379.2 | 379.2 |
| Revenue | |||
| Year ended | Year ended | ||
| 31 March | 31 March | ||
| 2026 | 2025 | % growth | |
| £m | £m | contribution | |
Organic at constant currency (“organic”) | 2,588.2 | 2,218.8 | 16.6% |
Acquired and disposed revenue | 56.1 | 29.3 | 1.0% |
Constant currency adjustment | (62.0) | (2.7)% | |
Continuing operations – reported | 2,582.3 | 2,248.1 | 14.9% |
Adjusted* profit before interest and taxation | Adjusted* profit before taxation | |||||
| Year ended | Year ended | Year ended | Year ended | |||
| 31 March | 31 March | 31 March | 31 March | |||
| 2026 | 2025 | % growth | 2026 | 2025 | % growth | |
| £m | £m | contribution | £m | £m | contribution | |
Organic at constant currency (“organic”) | 589.1 | 487.2 | 20.9% | 566.4 | 460.3 | 23.1% |
Acquired and disposed profit | 19.3 | (0.9) | 4.1% | 11.9 | (0.9) | 2.7% |
Constant currency adjustment | (13.9) | (2.8)% | (13.8) | (2.9)% | ||
Continuing operations – reported | 594.5 | 486.3 | 22.2% | 564.5 | 459.4 | 22.9% |
Revenue | Adjusted* profit before taxation | |||||
| Year ended | Year ended | Year ended | Year ended | |||
| 31 March | 31 March | 31 March | 31 March | |||
| 2026 | 2025 | % growth | 2026 | 2025 | % growth | |
| £m | £m | contribution | £m | £m | contribution | |
Organic at constant currency (“organic”) | 931.1 | 874.0 | 6.5% | 247.5 | 218.8 | 13.1% |
Acquired and disposed revenue/profit | 24.7 | 28.0 | (0.6)% | 7.8 | (0.9) | 4.1% |
Constant currency adjustment | (8.3) | (0.9)% | (1.7) | (0.8)% | ||
Continuing operations – reported | 947.5 | 902.0 | 5.0% | 253.6 | 217.9 | 16.4% |
Revenue | Adjusted* profit before taxation | |||||
| Year ended | Year ended | Year ended | Year ended | |||
| 31 March | 31 March | 31 March | 31 March | |||
| 2026 | 2025 | % growth | 2026 | 2025 | % growth | |
| £m | £m | contribution | £m | £m | contribution | |
Organic at constant currency (“organic”) | 1,052.4 | 775.7 | 35.7% | 251.7 | 185.5 | 35.7% |
Acquired and disposed revenue/profit | 22.8 | 0.9 | 2.7% | 7.9 | – | 4.3% |
Constant currency adjustment | (37.5) | (4.8)% | (9.0) | (4.9)% | ||
Continuing operations – reported | 1,037.7 | 776.6 | 33.6% | 250.6 | 185.5 | 35.1% |
Revenue | Adjusted* profit before taxation | |||||
| Year ended | Year ended | Year ended | Year ended | |||
| 31 March | 31 March | 31 March | 31 March | |||
| 2026 | 2025 | % growth | 2026 | 2025 | % growth | |
| £m | £m | contribution | £m | £m | contribution | |
Organic at constant currency (“organic”) | 606.0 | 570.0 | 6.3% | 143.1 | 130.6 | 9.6% |
Acquired and disposed revenue/profit | 8.6 | 0.4 | 1.4% | 3.6 | – | 2.3% |
Constant currency adjustment | (16.2) | (2.8)% | (3.6) | (2.4)% | ||
Continuing operations – reported | 598.4 | 570.4 | 4.9% | 143.1 | 130.6 | 9.5% |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Profit before interest and taxation (EBIT) | 520.7 | 411.2 |
| Add back: | ||
Acquisition items (note 1) | 4.4 | 20.2 |
Disposal of operations and impairment of associate (note 1) | 6.2 | (2.0) |
Amortisation of acquired intangible assets (note 1) | 63.2 | 56.9 |
Adjusted profit before interest and taxation (Adjusted EBIT) | 594.5 | 486.3 |
Depreciation, impairment and amortisation (excluding acquired intangible assets) | 67.0 | 66.5 |
Adjusted EBITDA | 661.5 | 552.8 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Operating profit | 525.8 | 409.5 |
| Add back: | ||
Acquisition items (note 1) | 4.4 | 20.2 |
Amortisation of acquired intangible assets (note 1) | 63.2 | 56.9 |
Adjusted operating profit | 593.4 | 486.6 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Net cash from operating activities (note 26) | 480.6 | 492.4 |
| Add: | ||
Net acquisition costs paid | 6.2 | 4.9 |
Prepayment for acquisition made post year‑end, included in receivables | 8.5 | – |
Taxes paid | 112.5 | 103.3 |
Proceeds from sale of property, plant and equipment and capitalised development costs | 1.2 | 0.9 |
Share awards vested not settled by own shares (note 24) | 5.5 | 3.5 |
Deferred consideration paid in excess of payable estimated on acquisition (note 25) | 6.7 | 0.1 |
| Less: | ||
Purchase of property, plant and equipment (excluding Right of use assets) | (54.9) | (43.8) |
Purchase of computer software and other intangibles | (1.3) | (1.8) |
Development costs capitalised | (14.8) | (13.8) |
Adjusted operating cash flow | 550.2 | 545.7 |
Adjusted cash conversion % (adjusted operating cash flow/adjusted operating profit) | 93% | 112% |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Profit after tax | 372.3 | 296.4 |
Adjustments 1 | 58.4 | 59.4 |
Adjusted profit after tax 1 | 430.7 | 355.8 |
Total equity | 2,168.0 | 1,899.4 |
Less net retirement benefit assets | (1.9) | (2.0) |
Deferred tax liabilities on retirement benefits | 0.4 | 0.6 |
Cumulative fair value adjustments on equity investments through other comprehensive income | 3.4 | (3.3) |
Cumulative amortisation and impairment of acquired intangible assets | 568.2 | 505.9 |
Cumulative amortisation and impairment of acquired intangible assets – held for sale | 3.0 | – |
Historical adjustments to goodwill 2 | 89.5 | 89.5 |
Total Invested Capital | 2,830.6 | 2,490.1 |
Average Total Invested Capital 3 | 2,660.4 | 2,374.1 |
Adjusted Return on Total Invested Capital (Adjusted ROTIC) 4 | 16.2% | 15.0% |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Profit before tax | 490.7 | 384.3 |
Adjustments 1 | 73.8 | 75.1 |
Net finance costs | 30.0 | 26.9 |
Lease interest | (4.3) | (4.6) |
Adjusted operating profit 1 after share of results of associates and lease interest | 590.2 | 481.7 |
Computer software costs within other intangible assets | 2.1 | 3.2 |
Capitalised development costs within other intangible assets | 54.8 | 51.4 |
Other intangibles within other intangible assets | 3.5 | 3.0 |
Property, plant and equipment | 310.3 | 283.2 |
Inventories | 322.2 | 300.3 |
Trade and other receivables | 601.0 | 485.9 |
Assets classified as held for sale 5 | 13.2 | – |
Current trade and other payables | (396.9) | (343.3) |
Current lease liabilities | (25.2) | (23.1) |
Current provisions | (30.0) | (44.5) |
Net tax receivable | 14.0 | 4.2 |
Non‑current trade and other payables | (24.6) | (24.5) |
Non‑current provisions | (13.3) | (11.2) |
Non‑current lease liabilities | (82.6) | (86.5) |
Liabilities classified as held for sale | (4.1) | – |
Add back contingent purchase consideration | 17.2 | 27.0 |
Capital Employed | 761.6 | 625.1 |
Average Capital Employed 3 | 693.4 | 632.4 |
Adjusted Return on Capital Employed (Adjusted ROCE) 4 | 85.1% | 76.2% |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Interest receivable | 5.8 | 4.9 |
Net interest credit on pension plan assets | 0.2 | 1.5 |
6.0 | 6.4 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Interest payable on borrowings | 28.1 | 27.9 |
Interest payable on lease obligations | 4.3 | 4.6 |
Amortisation of finance costs | 1.1 | 0.5 |
Other interest payable | 2.4 | 0.2 |
Fair value movement on derivative financial instruments | 0.1 | 0.1 |
36.0 | 33.3 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Revenue | 2,582.3 | 2,248.1 |
Direct materials/direct labour | (1,115.3) | (944.9) |
Production overhead | (180.1) | (169.6) |
Selling costs | (208.9) | (203.3) |
Distribution costs | (36.8) | (35.0) |
Administrative expenses | (515.4) | (485.8) |
Operating profit | 525.8 | 409.5 |
Share of profit/(loss) of associate | 1.1 | (1.3) |
(Loss)/profit on disposal of operations | (6.2) | 3.0 |
Profit before interest and taxation | 520.7 | 411.2 |
Net finance expense | (30.0) | (26.9) |
Profit before taxation | 490.7 | 384.3 |
| Year ended | Year ended | ||
| 31 March | 31 March | ||
| 2026 | 2025 | ||
| £m | £m | ||
| Profit before taxation is stated after charging/(crediting): | |||
Depreciation | 55.0 | 50.9 | |
Amortisation | 76.0 | 69.3 | |
Impairment (reversal)/loss of other intangible assets | (0.8) | 3.1 | |
Impairment of property, plant and equipment | – | 0.1 | |
Net impairment loss/(reversal) on trade receivables (note 16) | 2.3 | (0.5) | |
Research costs* | 107.8 | 94.6 | |
Foreign exchange loss | 1.8 | 1.1 | |
Loss/(profit) on disposal of operations (note 30) | 6.2 | (3.0) | |
| Loss/(profit) on sale of property, plant and equipment and computer | |||
software | 0.7 | (0.2) | |
Cost of inventories recognised as an expense | 1,295.4 | 1,100.6 | |
Staff costs (note 7) | 657.6 | 609.1 | |
Auditors’ remuneration | Audit services to the Company | 0.9 | 0.7 |
Audit of the Company’s subsidiaries | 2.4 | 2.4 | |
Total audit fees | 3.3 | 3.1 | |
Audit related fees – interim review | 0.1 | 0.1 | |
Other services** | – | – | |
Total non‑audit fees | 0.1 | 0.1 | |
Total fees | 3.4 | 3.2 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| Number | Number | |
United States of America | 3,062 | 3,025 |
Mainland Europe | 1,951 | 1,786 |
United Kingdom | 2,878 | 2,734 |
Asia Pacific | 1,280 | 1,225 |
Other countries | 290 | 268 |
9,038 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| Number | Number | |
United States of America | 3,077 | 2,985 |
Mainland Europe | 1,969 | 1,803 |
United Kingdom | 2,800 | 2,652 |
Asia Pacific | 1,336 | 1,320 |
Other countries | 279 | 278 |
9,461 | 9,038 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025* | |
| £m | £m | |
Wages and salaries | 532.8 | 497.8 |
Social security costs | 71.9 | 63.9 |
Pension costs (note 29) | 22.8 | 21.1 |
Share‑based payment charge (note 24) | 30.1 | 26.3 |
657.6 | 609.1 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Wages, salaries and fees | 7.7 | 8.0 |
Pension costs | – | – |
Share‑based payment charge | 4.4 | 4.6 |
12.1 | 12.6 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Current tax | ||
UK corporation tax at 25% (2025: 25%) | 31.6 | 25.9 |
Overseas taxation | 80.6 | 81.2 |
Adjustments in respect of prior years | (7.1) | (3.7) |
Total current tax charge | 105.1 | 103.4 |
| Deferred tax | ||
Origination and reversal of timing differences | 8.5 | (18.3) |
Adjustments in respect of prior years | 4.8 | 2.8 |
Total deferred tax charge/(credit) | 13.3 | (15.5) |
Total tax charge recognised in the Consolidated Income Statement | 118.4 | 87.9 |
| Reconciliation of the effective tax rate: | ||
Profit before tax | 490.7 | 384.3 |
Tax at the UK corporation tax rate of 25% (2025: 25%) | 122.7 | 96.1 |
Overseas tax rate differences | (4.1) | (6.3) |
Tax incentives, exemptions and credits (including patent box, R&D and High‑Tech status) | (11.0) | (9.4) |
Permanent differences | 13.1 | 8.4 |
Adjustments in respect of prior years | (2.3) | (0.9) |
Total tax charge recognised in the Consolidated Income Statement | 118.4 | 87.9 |
Effective tax rate | 24.1% | 22.9% |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Adjusted * profit before tax | 564.5 | 459.4 |
Total tax charge on adjusted * profit | 133.8 | 103.6 |
Effective tax rate | 23.7% | 22.6% |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Current tax | ||
Retirement benefits | – | – |
| Deferred tax (note 22) | ||
Retirement benefits | – | (7.4) |
Effective portion of changes in fair value of cash flow hedges | 0.2 | 0.1 |
0.2 | (7.3) |
| Per ordinary share | ||||
| Year ended | Year ended | Year ended | Year ended | |
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| pence | pence | £m | £m | |
| Amounts recognised as distributions to shareholders in the year | ||||
Final dividend for the year ended 31 March 2025 (31 March 2024) | 14.12 | 13.20 | 53.3 | 49.8 |
Interim dividend for the year ended 31 March 2026 (31 March 2025) | 9.63 | 9.00 | 36.4 | 34.0 |
89.7 | 83.8 | |||
| Dividends declared in respect of the year | ||||
Interim dividend for the year ended 31 March 2026 (31 March 2025) | 9.63 | 9.00 | 36.4 | 34.0 |
Proposed final dividend for the year ended 31 March 2026 (31 March 2025) | 15.11 | 14.12 | 57.0 | 53.3 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Cost | ||
At beginning of year | 1,263.3 | 1,211.0 |
Additions (note 25) | 239.5 | 72.7 |
Acquisition adjustments to prior years (note 25) | – | 5.6 |
Disposals (note 30) | (2.4) | (2.0) |
Reclassified as held for sale (note 32) | (1.1) | – |
Exchange adjustments | 9.7 | (24.0) |
At end of year | 1,509.0 | 1,263.3 |
| Provision for impairment | ||
At beginning and end of year | – | – |
Carrying amounts | 1,509.0 | 1,263.3 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Safety | ||
Fire | 353.8 | 190.5 |
Doors, Security and Elevators | 109.8 | 108.3 |
Safety Interlocks and Corrosion Monitoring | 125.6 | 124.5 |
Bursting Discs | 8.8 | 9.0 |
598.0 | 432.3 | |
| Environmental & Analysis | ||
Water | 214.4 | 146.1 |
Analysis | 76.2 | 78.8 |
Environmental Monitoring | 32.5 | 32.8 |
Gas Detection | 25.2 | 25.2 |
348.3 | 282.9 | |
| Healthcare | ||
Life Sciences | 38.5 | 38.6 |
Healthcare Assessment | 233.8 | 233.4 |
Therapeutic Solutions | 290.4 | 276.1 |
562.7 | 548.1 | |
Total Group | 1,509.0 | 1,263.3 |
Risk adjusted discount rate | Short‑term growth rates | Long‑term growth rates | ||||
| 31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
Fire | 15.38% | 15.55% | 9.59% | 10.77% | 2.09% | 2.09% |
Water | 11.40% | 12.26% | 10.53% | 10.32% | 1.85% | 1.94% |
Healthcare Assessment | 14.40% | 14.09% | 11.23% | 8.43% | 2.10% | 2.18% |
Therapeutic Solutions | 14.14% | 13.68% | 11.23% | 8.43% | 1.98% | 2.06% |
| Acquired intangible assets | ||||||||
| Internally | ||||||||
| generated | ||||||||
| Customer | Trademarks, | capitalised | ||||||
| and supplier | Technical | brands and | development | Computer | Other | |||
relationship 1 | know‑how 2 | patents 3 | Total | costs 4 | software | intangibles 5 | Total | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
| Cost | ||||||||
At 1 April 2024 | 532.3 | 311.2 | 125.1 | 968.6 | 152.1 | 23.0 | 7.1 | 1,150.8 |
| Assets of businesses | ||||||||
acquired | 39.4 | 29.2 | 6.6 | 75.2 | – | – | – | 75.2 |
Transfer between categories | – | – | – | – | (0.7) | 0.7 | – | – |
Additions at cost | – | – | – | – | 13.8 | 1.1 | 0.7 | 15.6 |
Assets of business sold | (0.1) | (0.1) | (0.1) | (0.3) | – | (0.3) | – | (0.6) |
Disposals and retirements | – | – | – | – | (4.1) | (0.9) | (0.3) | (5.3) |
Exchange adjustments | (9.8) | (6.6) | (2.8) | (19.2) | (2.2) | (0.1) | (0.1) | (21.6) |
At 31 March 2025 | 561.8 | 333.7 | 128.8 | 1,024.3 | 158.9 | 23.5 | 7.4 | 1,214.1 |
| Assets of businesses | ||||||||
acquired (note 25) | 113.7 | 84.2 | 30.3 | 228.2 | – | 0.4 | 0.4 | 229.0 |
Transfer between categories | – | – | – | – | (0.1) | 0.1 | – | – |
Additions at cost | – | – | – | – | 14.8 | 1.0 | 0.3 | 16.1 |
Assets of business sold | – | – | – | – | (1.2) | (0.1) | – | (1.3) |
Disposals and retirements | – | – | – | – | (8.9) | (2.3) | (0.9) | (12.1) |
| Reclassified as held for sale | ||||||||
(note 32) | (4.2) | (3.6) | (0.9) | (8.7) | (1.0) | (3.0) | – | (12.7) |
Exchange adjustments | 5.4 | 1.8 | 1.9 | 9.1 | 0.3 | – | 0.5 | 9.9 |
At 31 March 2026 | 676.7 | 416.1 | 160.1 | 1,252.9 | 162.8 | 19.6 | 7.7 | 1,443.0 |
| Accumulated amortisation | ||||||||
| & impairment | ||||||||
At 1 April 2024 | 286.6 | 106.5 | 65.1 | 458.2 | 100.3 | 19.7 | 3.6 | 581.8 |
Charge for the year | 26.3 | 24.0 | 6.6 | 56.9 | 10.4 | 1.3 | 0.7 | 69.3 |
Transfer between categories | – | – | – | – | (0.7) | 0.7 | – | – |
Impairment | – | – | – | – | 3.1 | – | – | 3.1 |
Assets of business sold | (0.1) | – | – | (0.1) | – | (0.3) | – | (0.4) |
Disposals and retirements | – | – | – | – | (4.1) | (0.8) | – | (4.9) |
Exchange adjustments | (5.3) | (2.5) | (1.3) | (9.1) | (1.5) | (0.3) | 0.1 | (10.8) |
At 31 March 2025 | 307.5 | 128.0 | 70.4 | 505.9 | 107.5 | 20.3 | 4.4 | 638.1 |
Charge for the year | 29.3 | 25.5 | 8.4 | 63.2 | 10.9 | 1.3 | 0.6 | 76.0 |
Impairment | – | – | – | – | (0.8) | – | – | (0.8) |
Assets of business sold | – | – | – | – | (0.4) | (0.1) | – | (0.5) |
Disposals and retirements | – | – | – | – | (8.7) | (2.2) | (0.7) | (11.6) |
| Reclassified as held for sale | ||||||||
(note 32) | (1.1) | (1.5) | (0.4) | (3.0) | (1.0) | (1.9) | – | (5.9) |
Exchange adjustments | 1.7 | (0.3) | 0.7 | 2.1 | 0.5 | 0.1 | (0.1) | 2.6 |
At 31 March 2026 | 337.4 | 151.7 | 79.1 | 568.2 | 108.0 | 17.5 | 4.2 | 697.9 |
| Carrying amounts | ||||||||
At 31 March 2026 | 339.3 | 264.4 | 81.0 | 684.7 | 54.8 | 2.1 | 3.5 | 745.1 |
At 31 March 2025 | 254.3 | 205.7 | 58.4 | 518.4 | 51.4 | 3.2 | 3.0 | 576.0 |
| Owned assets | |||||
| Right‑of‑use | Leasehold | Plant, | |||
| assets | Freehold land | buildings and | equipment | ||
| (Note 28) | and buildings | improvements | and vehicles | Total | |
| £m | £m | £m | £m | £m | |
| Cost | |||||
At 1 April 2024 | 166.2 | 80.5 | 32.3 | 234.1 | 513.1 |
Transfer between category | – | (0.7) | 3.0 | (2.3) | – |
Assets of businesses acquired | 3.4 | 2.4 | 1.0 | 4.2 | 11.0 |
Assets of business sold | (1.9) | – | – | (4.8) | (6.7) |
Additions at cost | 49.1 | 5.4 | 6.0 | 32.4 | 92.9 |
Disposals and retirements | (5.8) | (0.1) | (0.7) | (8.1) | (14.7) |
Exchange adjustments | (2.7) | (0.7) | (0.5) | (3.1) | (7.0) |
At 31 March 2025 | 208.3 | 86.8 | 41.1 | 252.4 | 588.6 |
Transfer between category | (1.3) | 1.0 | 0.4 | (0.1) | – |
Assets of businesses acquired (note 25) | 11.5 | – | 1.0 | 6.7 | 19.2 |
Assets of business sold | (3.3) | – | (1.4) | (7.3) | (12.0) |
Additions at cost | 13.0 | 14.8 | 5.7 | 34.4 | 67.9 |
Disposals and retirements | (6.3) | – | (0.4) | (13.5) | (20.2) |
Reclassified as held for sale (note 32) | (1.3) | (3.7) | (0.6) | (6.3) | (11.9) |
Exchange adjustments | (1.1) | 2.2 | (0.1) | 1.6 | 2.6 |
At 31 March 2026 | 219.5 | 101.1 | 45.7 | 267.9 | 634.2 |
| Accumulated depreciation & impairment | |||||
At 1 April 2024 | 86.8 | 20.3 | 18.7 | 150.5 | 276.3 |
Transfer between category | – | (0.3) | 1.1 | (0.8) | – |
Charge for the year | 24.9 | 1.5 | 3.5 | 21.0 | 50.9 |
Impairment | – | – | – | 0.1 | 0.1 |
Assets of business sold | (1.2) | – | – | (3.8) | (5.0) |
Disposals and retirements | (4.8) | – | (0.5) | (7.6) | (12.9) |
Exchange adjustments | (1.8) | (0.2) | (0.3) | (1.7) | (4.0) |
At 31 March 2025 | 103.9 | 21.3 | 22.5 | 157.7 | 305.4 |
Transfer between category | (1.3) | 0.7 | – | 0.6 | – |
Charge for the year | 26.4 | 1.5 | 4.0 | 23.1 | 55.0 |
Impairment | – | – | – | – | – |
Assets of business sold | (2.9) | – | (0.9) | (4.8) | (8.6) |
Disposals and retirements | (6.3) | – | (0.1) | (12.4) | (18.8) |
Reclassified as held for sale (note 32) | (0.8) | (2.6) | (0.2) | (5.2) | (8.8) |
Exchange adjustments | (1.2) | 0.3 | 0.8 | (0.2) | (0.3) |
At 31 March 2026 | 117.8 | 21.2 | 26.1 | 158.8 | 323.9 |
| Carrying amounts | |||||
At 31 March 2026 | 101.7 | 79.9 | 19.6 | 109.1 | 310.3 |
At 31 March 2025 | 104.4 | 65.5 | 18.6 | 94.7 | 283.2 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Interest in associate | 11.1 | 0.5 |
| Financial assets at fair value through other comprehensive income | ||
– Equity instruments | 10.3 | 12.0 |
21.4 | 12.5 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At beginning of the year | 0.5 | 1.8 |
Impairment of investment | – | (1.0) |
Group’s share of profit/(loss) of associate | 1.1 | (0.3) |
Additions | 10.0 | – |
Deemed disposal of associate | (0.5) | – |
11.1 | 0.5 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Aggregated amounts relating to associate | ||
Non‑current assets | 10.1 | 2.0 |
Current assets | 7.9 | 0.7 |
Current liabilities | (2.7) | (0.2) |
Net assets | 15.3 | 2.5 |
Group’s share of net assets of associate | 5.4 | 0.6 |
Revenue | 9.3 | 0.6 |
Profit/(loss) | 3.0 | (1.5) |
Group’s share of profit/(loss) of associate | 1.1 | (0.3) |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Unlisted securities | ||
At beginning of the year | 12.0 | 18.0 |
Additions in the year | 5.0 | – |
Changes in fair value recognised in other comprehensive income | (6.7) | (6.0) |
At end of the year | 10.3 | 12.0 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At beginning of the year | 60.9 | 55.6 |
Write downs of inventories recognised as an expense | 2.9 | 5.3 |
Recognition of provisions for businesses acquired | 2.3 | 1.6 |
Derecognition of provisions for businesses disposed | (1.2) | (0.1) |
Utilisation and amounts reversed against inventories previously impaired | (2.4) | (0.7) |
Reclassified as held for sale | (1.5) | – |
Exchange adjustments | (0.1) | (0.8) |
At end of the year | 60.9 | 60.9 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Trade receivables | 434.9 | 376.1 |
Allowance for doubtful debts | (8.9) | (6.3) |
426.0 | 369.8 | |
Other receivables | 42.0 | 29.2 |
Prepayments | 37.0 | 32.7 |
Contract assets (note 18) | 96.0 | 54.2 |
601.0 | 485.9 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At beginning of the year | 6.3 | 7.1 |
Net impairment loss/(reversal) | 2.3 | (0.5) |
Amounts recovered against trade receivables previously written down/amounts utilised | (0.8) | (0.9) |
Recognition of provisions for businesses acquired | 1.0 | 0.7 |
Exchange adjustments | 0.1 | (0.1) |
At end of the year | 8.9 | 6.3 |
| Gross trade | Trade receivables | |||
| receivables | net of doubtful debts | |||
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | £m | £m | |
Not yet due | 332.9 | 293.1 | 332.2 | 292.8 |
Up to one month overdue | 61.4 | 52.5 | 61.1 | 52.4 |
Between one and two months overdue | 15.0 | 10.9 | 14.8 | 10.8 |
Between two and three months overdue | 6.4 | 5.3 | 5.6 | 5.2 |
Over three months overdue | 19.2 | 14.3 | 12.3 | 8.6 |
434.9 | 376.1 | 426.0 | 369.8 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Trade payables | 149.4 | 131.5 |
Other taxation and social security | 13.2 | 12.2 |
Other payables | 11.5 | 6.7 |
Accruals | 170.3 | 140.0 |
Contract liabilities (note 18) | 50.2 | 50.9 |
Deferred government grant income | 2.3 | 2.0 |
396.9 | 343.3 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Contract costs | 1.9 | 1.4 |
Contract assets | 96.0 | 54.2 |
Contract liabilities current (note 17) | (50.2) | (50.9) |
Contract liabilities non‑current (note 20) | (16.9) | (18.1) |
Total contract liabilities | (67.1) | (69.0) |
Contract assets | Contract liabilities | |||
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | £m | £m | |
Amounts included in contract balances at the beginning of the year | 54.2 | 49.2 | (69.0) | (53.5) |
Transfers to receivables during the year | (54.8) | (46.7) | ||
| Performance obligations arising in the current reporting year | ||||
Increases as a result of billing ahead of performance | (106.2) | (96.1) | ||
Decreases as a result of revenue recognised in the year | 107.4 | 80.5 | ||
Increases as a result of performance in advance of billing | 87.6 | 52.7 | ||
Amounts arising through business combinations | 9.5 | – | – | (0.5) |
Exchange movements | (0.5) | (1.0) | 0.7 | 0.6 |
Amounts included in contract balances at the end of the year | 96.0 | 54.2 | (67.1) | (69.0) |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Overdrafts | 1.4 | 0.5 |
Unsecured loan notes falling due within one year | 47.5 | 35.1 |
Total borrowings falling due within one year | 48.9 | 35.6 |
Unsecured loan notes falling due after more than one year | 627.8 | 659.9 |
Unsecured bank loans falling due after more than one year | 128.9 | 43.9 |
Total borrowings falling due after more than one year | 756.7 | 703.8 |
Total borrowings | 805.6 | 739.4 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Other payables | 1.6 | 1.4 |
Other taxation and social security | 0.1 | – |
Accruals | 5.2 | 4.2 |
Contract liabilities (note 18) | 16.9 | 18.1 |
Deferred government grant income | 0.8 | 0.8 |
24.6 | 24.5 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Current | 30.0 | 44.5 |
Non‑current | 13.3 | 11.2 |
43.3 | 55.7 |
| Contingent | Legal, | ||||
| purchase | Product | contractual | |||
| consideration | Dilapidations | warranty | and other | Total | |
| £m | £m | £m | £m | £m | |
At 31 March 2025 | 27.0 | 4.2 | 10.4 | 14.1 | 55.7 |
Additional provision in the year | 0.1 | 0.6 | 2.7 | 6.2 | 9.6 |
Arising on acquisition (note 25) | 5.4 | – | 1.0 | 2.0 | 8.4 |
Liabilities of business sold | – | – | – | (0.1) | (0.1) |
Utilised during the year | (12.0) | – | (1.4) | (6.2) | (19.6) |
Released during the year | (3.6) | (0.2) | (1.6) | (5.3) | (10.7) |
Reclassified as Held For Sale (note 32) | – | – | (0.1) | – | (0.1) |
Exchange adjustments | 0.3 | – | (0.1) | (0.1) | 0.1 |
At 31 March 2026 | 17.2 | 4.6 | 10.9 | 10.6 | 43.3 |
| Retirement | Acquired | Accelerated | Short‑term | Goodwill | Capitalised | |||
| benefit | intangible | tax | timing | Share‑based | timing | development | ||
| obligations | assets | depreciation | differences | payment | differences | costs | Total | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 April 2025 | (0.6) | (124.3) | (9.8) | 22.4 | 10.4 | 15.6 | 17.3 | (69.0) |
Credit/(charge) to Consolidated Income | ||||||||
Statement | 0.2 | 13.0 | (2.3) | 3.0 | 0.8 | (9.1) | (18.9) | (13.3) |
Credit/(charge) to Consolidated Statement | ||||||||
| of Comprehensive Income | ||||||||
and Expense | – | – | 0.2 | – | – | – | – | 0.2 |
Credit to equity | – | – | – | – | 3.3 | – | – | 3.3 |
| Arising on acquisition | ||||||||
(note 25) | – | (57.2) | 0.2 | (0.2) | – | – | – | (57.2) |
| Disposal of business | ||||||||
(note 30) | – | – | (0.1) | – | – | – | – | (0.1) |
| Reclassified as held for sale | ||||||||
(note 32) | – | 1.5 | – | – | – | (2.2) | – | (0.7) |
Exchange adjustments | – | (1.5) | (0.2) | – | – | (0.5) | (0.7) | (2.9) |
At 31 March 2026 | (0.4) | (168.5) | (12.0) | 25.2 | 14.5 | 3.8 | (2.3) | (139.7) |
| Retirement | Acquired | Accelerated | Short‑term | Goodwill | Capitalised | |||
| benefit | intangible | tax | timing | Share‑based | timing | development | ||
| obligations | assets | depreciation | differences | payment | differences | costs | Total | |
| £m | £m | £m | £m | £m | £m | £m | £m | |
At 1 April 2024 | (7.9) | (123.4) | (8.6) | 13.2 | 8.3 | 24.2 | 19.6 | (74.6) |
Credit/(charge) to Consolidated Income | ||||||||
Statement | (0.1) | 14.8 | (1.4) | 11.7 | 1.3 | (8.3) | (2.5) | 15.5 |
Credit/(charge) to Consolidated Statement | ||||||||
| of Comprehensive Income | ||||||||
and Expense | 7.4 | – | – | (0.1) | – | – | – | 7.3 |
Credit to equity | – | – | – | – | 0.8 | – | – | 0.8 |
Arising on acquisition | – | (18.5) | – | (0.5) | – | 0.2 | 0.3 | (18.5) |
Disposal of business | – | 0.1 | – | – | – | – | – | 0.1 |
Exchange adjustments | – | 2.7 | 0.2 | (1.9) | – | (0.5) | (0.1) | 0.4 |
At 31 March 2025 | (0.6) | (124.3) | (9.8) | 22.4 | 10.4 | 15.6 | 17.3 | (69.0) |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Deferred tax liability | (144.0) | (73.4) |
Deferred tax asset | 4.3 | 4.4 |
Net deferred tax liability | (139.7) | (69.0) |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At beginning of year | (69.0) | (74.6) |
| Credit/(charge) to Consolidated Income Statement: | ||
UK | 0.1 | (2.0) |
Overseas | (13.4) | 17.5 |
Charge to Consolidated Statement of Comprehensive Income | 0.2 | 7.3 |
Credit to equity | 3.3 | 0.8 |
Arising on acquisition (note 25) | (57.2) | (18.8) |
Deferred tax of business sold | (0.1) | 0.1 |
Reclassified as held for sale (note 32) | (0.7) | – |
Exchange adjustments | (2.9) | 0.7 |
At end of year | (139.7) | (69.0) |
| Issued and fully paid | ||
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Ordinary shares of 10p each | 38.0 | 38.0 |
Year ended 31 March 2026 | Year ended 31 March 2025 | |||||
| Equity‑settled | Cash‑settled | Total | Equity‑settled | Cash‑settled | Total | |
| £m | £m | £m | £m | £m | £m | |
Share incentive plan | 1.5 | – | 1.5 | 1.0 | – | 1.0 |
Executive share plan | 26.3 | 2.3 | 28.6 | 24.7 | 0.6 | 25.3 |
27.8 | 2.3 | 30.1 | 25.7 | 0.6 | 26.3 |
| 2026 | 2025 | |
| Number | Number | |
| of shares | of shares | |
| awarded | awarded | |
Outstanding at beginning of year | 3,207,053 | 3,109,381 |
Granted during the year | 1,070,148 | 1,183,577 |
Vested during the year (pro–rated for ‘good leavers’) | (1,110,576) | (883,967) |
Lapsed during the year | (340,028) | (201,938) |
Outstanding at end of year | 2,826,597 | 3,207,053 |
Exercisable at end of year | – | – |
2026 | 2025 | 2024 | |
Expected life (years) | 2 or 3 | 2 or 3 | 2 or 3 |
Share price on date of grant (p) | 3130 | 2356 | 2240 |
Option price (p) | Nil | Nil | Nil |
Fair value per option (%) | 100% | 100% | 100% |
Fair value per option (p) | 3130 | 2356 | 2240 |
| Percentage of | Annualised | ||||
| Share Capital | Acquired | ||||
Business | Sector | Country | Acquisition Date | Acquired | Revenue £m |
| Nu Perspectives Limited | |||||
| (Nu Perspectives) | Healthcare | United Kingdom | 3 April 2025 | 100% | 1.1 |
MC Steering B.V. (Brownline) | Environmental & Analysis | Netherlands | 25 August 2025 | 100% | 30.5 |
E2S Group Limited (E2S) | Safety | United Kingdom | 5 December 2025 | 100% | 44.0 |
Safetec S.r.l (Safetec) | Safety | Italy | 9 January 2026 | 100% | 23.0 |
| Altomed Group Holdings | |||||
| Limited (Altomed) | Healthcare | United Kingdom | 27 February 2026 | 100% | 13.7 |
Total | 112.3 |
| Total | ||||
| 2026 | Brownline | E2S | Other | |
| £m | £m | £m | £m | |
| Non‑current assets | ||||
Other intangible assets | 229.0 | 65.9 | 110.0 | 53.1 |
Property, plant and equipment | 19.2 | 12.7 | 5.2 | 1.3 |
| Current assets | ||||
Inventories | 17.1 | 3.4 | 10.0 | 3.7 |
Trade and other receivables | 39.2 | 9.0 | 9.0 | 21.2 |
Cash and bank balances | 30.2 | 5.6 | 6.8 | 17.8 |
Total assets | 334.7 | 96.6 | 141.0 | 97.1 |
| Current liabilities | ||||
Trade and other payables | (20.1) | (5.6) | (4.4) | (10.1) |
Borrowings | (19.0) | (18.9) | – | (0.1) |
Lease liabilities | (2.1) | (0.9) | (0.5) | (0.7) |
Provisions | (2.4) | (1.3) | (0.2) | (0.9) |
Tax liabilities | (4.8) | (1.6) | (1.8) | (1.4) |
| Non‑current liabilities | ||||
Lease liabilities | (9.4) | (5.2) | (3.6) | (0.6) |
Provisions | (0.6) | – | (0.5) | (0.1) |
Deferred tax liabilities | (57.2) | (16.5) | (27.9) | (12.8) |
Total liabilities | (115.6) | (50.0) | (38.9) | (26.7) |
Net assets of businesses acquired | 219.1 | 46.6 | 102.1 | 70.4 |
Initial cash consideration paid | 453.6 | 114.0 | 234.3 | 105.3 |
Other amounts to be (received)/paid | (0.4) | (0.6) | (1.1) | 1.3 |
Contingent purchase consideration including retentions estimated to be paid | 5.4 | – | – | 5.4 |
Total consideration | 458.6 | 113.4 | 233.2 | 112.0 |
Total goodwill | 239.5 | 66.8 | 131.1 | 41.6 |
| Year ended | Year ended | |
| 2026 | 2025 | |
| £m | £m | |
Initial cash consideration paid | 453.6 | 115.5 |
Cash acquired on acquisitions | (30.2) | (10.5) |
Initial cash consideration adjustment paid on current year acquisitions | – | 1.0 |
Contingent consideration paid | 12.0 | 10.3 |
Net cash outflow relating to acquisitions | 435.4 | 116.3 |
Included in cash flows from operating activities | 6.7 | 0.1 |
Included in cash flows from investing activities | 428.7 | 116.2 |
| Total | Brownline | E2S | Other | ||
| £m | £m | £m | £m | ||
Revenue | Post acquisition | 41.9 | 21.3 | 14.3 | 6.3 |
Full year estimate | 124.6 | 34.9 | 45.6 | 44.1 | |
Profit after tax | Post acquisition | 10.5 | 4.8 | 4.5 | 1.2 |
Full year estimate | 31.4 | 8.3 | 13.8 | 9.3 |
| Total | |
| £m | |
| Current assets | |
Trade and other receivables | 0.3 |
Total assets | 0.3 |
| Non‑current liabilities | |
Deferred tax liability | (0.1) |
Total liabilities | (0.1) |
Net assets of business acquired | 0.2 |
Other paid | (0.2) |
Total consideration | (0.2) |
Total goodwill | 0.0 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Reconciliation of profit from operations to net cash inflow from operating activities: | ||
| Profit on continuing operations before finance income and expense, share of results of associate and profit | ||
on disposal of operations | 525.8 | 409.5 |
Non‑cash loss on hedging instruments | (0.1) | (0.6) |
Depreciation and impairment of property, plant and equipment | 55.0 | 51.0 |
Amortisation and impairment of computer software | 1.3 | 1.3 |
Amortisation of capitalised development costs and other intangibles | 11.5 | 11.1 |
Impairment (reversal)/charge of capitalised development costs | (0.8) | 3.1 |
Amortisation of acquired intangible assets | 63.2 | 56.9 |
Share‑based payment expense in excess of amounts paid | 17.2 | 21.9 |
Defined benefit pension plans administration cost less contributions from sponsoring companies | 0.4 | 0.4 |
Loss/(profit) on sale of property, plant and equipment, capitalised development costs and computer software | 0.7 | (0.2) |
Operating cash flows before movement in working capital | 674.2 | 554.4 |
(Increase)/decrease in inventories | (12.5) | 12.3 |
Increase in receivables | (90.5) | (20.9) |
Increase in payables and provisions | 31.4 | 44.7 |
| (Decrease)/increase to estimate and exchange difference on contingent consideration payable | ||
less amounts paid in excess of payable estimated on acquisition | (9.5) | 5.2 |
Cash generated from operations | 593.1 | 595.7 |
Taxation paid | (112.5) | (103.3) |
Net cash inflow from operating activities | 480.6 | 492.4 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Analysis of cash and cash equivalents | ||
Cash and bank balances | 143.4 | 313.2 |
Cash reclassified as held for sale (note 32) | 1.4 | – |
Overdrafts (included in current borrowings) | (1.4) | (0.5) |
Cash and cash equivalents | 143.4 | 312.7 |
| Net | Net | ||||||
| 31 March | cash/(debt) | (cash)/debt | Additions and | Exchange | 31 March | ||
| 2025 | Cash flow | acquired | disposed | reclassifications | adjustments | 2026 | |
| £m | £m | £m | £m | £m | £m | £m | |
| Analysis of net debt | |||||||
Cash and bank balances | 313.2 | (201.2) | 30.2 | (0.1) | (1.4) | 2.7 | 143.4 |
Cash reclassified as held for sale | – | – | – | – | 1.4 | – | 1.4 |
Overdrafts | (0.5) | (0.9) | – | – | – | – | (1.4) |
Cash and cash equivalents | 312.7 | (202.1) | 30.2 | (0.1) | – | 2.7 | 143.4 |
Loan notes falling due within one year | (35.1) | 35.1 | – | – | (47.5) | – | (47.5) |
Loan notes falling due after more than one year | (659.9) | – | – | – | 47.5 | (15.4) | (627.8) |
Bank loans falling due within one year | – | 19.0 | (19.0) | – | – | – | – |
Bank loans falling due after more than one year | (43.9) | (81.2) | – | – | – | (3.8) | (128.9) |
Lease Liabilities | (109.6) | 29.3 | (11.6) | 0.4 | (16.3) | – | (107.8) |
Lease Liabilities reclassified as held for sale | – | – | – | – | (0.5) | – | (0.5) |
Total net debt | (535.8) | (199.9) | (0.4) | 0.3 | (16.8) | (16.5) | (769.1) |
| Trade | |||||
| and other | |||||
| payables | |||||
| Total liabilities | falling | ||||
| from financing | due within | ||||
| Borrowings* | Overdraft | Leases | activities | one year | |
| £m | £m | £m | £m | £m | |
At 1 April 2024 | 711.9 | 0.3 | 83.7 | 795.9 | 296.5 |
Cash flows from financing activities | (8.9) | – | (28.8) | (37.7) | (33.0) |
Acquisition/disposal of subsidiaries | 46.7 | – | 2.4 | 49.1 | 12.0 |
Exchange adjustments | (10.8) | – | (1.8) | (12.6) | (4.2) |
Other changes ** | – | 0.2 | 54.1 | 54.3 | 72.0 |
At 31 March 2025 | 738.9 | 0.5 | 109.6 | 849.0 | 343.3 |
Cash flows from financing activities | 27.1 | – | (29.3) | (2.2) | (28.3) |
Acquisition/disposal of subsidiaries | 19.0 | – | 11.2 | 30.2 | 18.9 |
Exchange adjustments | 19.2 | – | – | 19.2 | (1.3) |
Other changes ** | – | 0.9 | 16.3 | 17.2 | 64.3 |
At 31 March 2026 | 804.2 | 1.4 | 107.8 | 913.4 | 396.9 |
| * Excluding overdrafts. |
| ** Other changes include movements in overdraft which is treated as cash, interest accruals, reclassifications from non‑current to current liabilities, lease additions |
Assets | Liabilities | |||
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | £m | £m | |
US Dollar – Total | 1,314.6 | 1,325.1 | 439.9 | 441.7 |
US Dollar – Monetary assets/liabilities | 348.7 | 299.7 | 402.3 | 407.1 |
Euro – Total | 941.3 | 683.6 | 658.8 | 518.2 |
Euro – Monetary assets/liabilities | 127.1 | 103.3 | 655.7 | 515.5 |
US Dollar | Euro | |||
| 31 March | 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2026 | 2025 | |
| £m | £m | £m | £m | |
Profit | 28.8 | 25.4 | 9.4 | 6.1 |
Other equity | 79.5 | 80.3 | 25.7 | 15.0 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Sterling denominated bank loans | – | – |
US Dollar denominated bank loans | – | – |
Euro denominated bank loans | 81.6 | – |
Swiss Franc denominated bank loans | 47.3 | 43.9 |
Total bank loans | 128.9 | 43.9 |
Overdrafts (principally Sterling and US Dollar denominated) | 1.4 | 0.5 |
Sterling denominated loan notes | 85.0 | 120.0 |
US Dollar denominated loan notes | 159.4 | 162.9 |
Euro denominated loan notes | 393.1 | 377.0 |
Swiss Franc denominated loan notes | 37.8 | 35.1 |
Total overdrafts and loan notes | 676.7 | 695.5 |
Total interest‑bearing financial liabilities | 805.6 | 739.4 |
Average exchange rate/£ | Foreign currency | Contract value | Fair value | |||||
| 31 March | 31 March | 31 March | 31 March | 31 March | 31 March | |||
| 31 March | 31 March | 2026 | 2025 | 2026 | 2025 | 2026 | 2025 | |
| 2026 | 2025 | m | m | £m | £m | £m | £m | |
| Foreign currency forward contracts | ||||||||
| not in a designated cash flow hedge | ||||||||
US Dollars vs GBP | – | – | – | – | – | – | – | – |
Euros vs GBP | – | 1.20 | – | 0.3 | – | 0.3 | – | – |
Other currencies | – | – | – | – | 42.8 | 18.5 | 0.1 | (0.1) |
| Foreign currency forward contracts | 42.8 | 18.8 | 0.1 | (0.1) | ||||
| in a designated cash flow hedge | ||||||||
US Dollars vs GBP | 1.34 | 1.27 | 15.2 | 14.8 | 11.6 | 11.5 | (0.2) | 0.2 |
Euros vs GBP | 1.14 | 1.17 | 27.2 | 25.3 | 23.7 | 21.2 | 0.1 | 0.2 |
Other currencies | – | – | – | – | 26.5 | 15.9 | (0.3) | 0.2 |
| Total foreign currency forward contracts | 61.8 | 48.6 | (0.4) | 0.6 | ||||
US Dollars vs GBP | 1.34 | 1.27 | 15.2 | 14.8 | 11.6 | 11.5 | (0.2) | 0.2 |
Euros vs GBP | 1.14 | 1.17 | 27.2 | 25.6 | 23.7 | 21.4 | 0.1 | 0.2 |
Other currencies | – | – | – | – | 69.3 | 34.5 | (0.2) | 0.1 |
Total | 104.6 | 67.4 | (0.3) | 0.5 | ||||
Amounts recognised in the Consolidated Income Statement | 0.1 | (0.1) | ||||||
Amounts recognised in the Consolidated Statement of Comprehensive Income and Expenditure | (0.4) | 0.6 | ||||||
(0.3) | 0.5 |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Analysis of movement in the Hedging reserve | ||
| Amounts removed from Consolidated Statement of Comprehensive Income and Expenditure and included | ||
in Consolidated Income Statement during the year | (0.5) | 1.1 |
Amounts recognised in the Consolidated Statement of Comprehensive Income and Expenditure | (0.4) | 0.6 |
| Net movement in the Hedging reserve in the year in relation to the effective portion of changes in fair value | ||
of cash flow hedges | (0.9) | 1.7 |
| Between | After | Effect of | ||||
| One to | two and | more than | Gross | discounting/ | ||
| two years | five years | five years | maturities | financing rates | Total | |
| £m | £m | £m | £m | £m | £m | |
| At 31 March 2026 | ||||||
Accruals | 3.2 | – | 2.0 | 5.2 | – | 5.2 |
Other payables | 1.3 | 0.3 | – | 1.6 | – | 1.6 |
Contingent purchase consideration | 4.9 | – | – | 4.9 | – | 4.9 |
Bank loans | – | 128.9 | – | 128.9 | – | 128.9 |
Loan notes | 68.2 | 271.5 | 381.3 | 721.0 | (93.2) | 627.8 |
Lease liabilities | 31.2 | 64.1 | 21.7 | 117.0 | (34.4) | 82.6 |
108.8 | 464.8 | 405.0 | 978.6 | (127.6) | 851.0 |
| Between | After | Effect of | ||||
| One to | two and | more than | Gross | discounting/ | ||
| two years | five years | five years | maturities | financing rates | Total | |
| £m | £m | £m | £m | £m | £m | |
| At 31 March 2025 | ||||||
Accruals | 3.0 | – | 1.2 | 4.2 | – | 4.2 |
Other payables | 0.8 | 0.3 | 0.3 | 1.4 | – | 1.4 |
Contingent purchase consideration | 3.9 | – | – | 3.9 | – | 3.9 |
Bank loans | – | 43.9 | – | 43.9 | – | 43.9 |
Loan notes | 69.5 | 253.8 | 467.2 | 790.5 | (130.6) | 659.9 |
Lease liabilities | 28.0 | 63.5 | 28.1 | 119.6 | (33.1) | 86.5 |
105.2 | 361.5 | 496.8 | 963.5 | (163.7) | 799.8 |
| Current | After 10 pp shift | |
| expected | in weighting | |
| future | towards upside | |
| cash flow | expectation | |
| £m | £m | |
Safe‑com | 1.9 | 2.0 |
| Plant, | |||
| Land | equipment | ||
| and | and | ||
| buildings | vehicles | Total | |
| £m | £m | £m | |
| Cost, net of accumulated depreciation and accumulated impairment | |||
At 1 April 2025 | 96.7 | 7.7 | 104.4 |
Assets of businesses acquired | 11.3 | 0.2 | 11.5 |
Additions and remeasurements | 9.7 | 3.3 | 13.0 |
Transfer between category | – | – | – |
Disposals and retirements (including disposal of business) | (0.4) | – | (0.4) |
Depreciation charge for the year | (22.7) | (3.7) | (26.4) |
Reclassified as held for sale (note 32) | (0.5) | – | (0.5) |
Exchange adjustments | (0.3) | 0.4 | 0.1 |
At 31 March 2026 | 93.8 | 7.9 | 101.7 |
| At 31 March 2026 | |||
Cost | 204.5 | 15.0 | 219.5 |
Accumulated depreciation and accumulated impairment | (110.7) | (7.1) | (117.8) |
Net carrying amount | 93.8 | 7.9 | 101.7 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At 1 April 2025 | 109.6 | 83.7 |
Additions and remeasurements | 12.5 | 49.5 |
Disposals | (0.3) | (0.8) |
Accretion of interest | 4.3 | 4.6 |
Payments | (29.3) | (28.8) |
Liabilities of business acquired (note 25) | 11.5 | 3.2 |
Reclassified as held for sale (note 32) | (0.5) | – |
Exchange adjustments | – | (1.8) |
At 31 March 2026 | 107.8 | 109.6 |
Current | 25.2 | 23.1 |
Non‑current | 82.6 | 86.5 |
At 31 March 2026 | 107.8 | 109.6 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Depreciation expense of right‑of‑use assets | 26.4 | 24.9 |
Interest expense on lease liabilities | 4.3 | 4.6 |
Expense relating to short‑term leases and leases of low‑value assets | 0.3 | 0.3 |
Total amount recognised in Consolidated Income Statement | 31.0 | 29.8 |
| 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2024 | |
| Key assumptions used (UK plans): | |||
Discount rate | 6.05% | 5.70% | 4.75% |
Pension increases LPI 2.5% | 2.10% | 2.05% | 2.05% |
Pension increases LPI 3.0% | 2.45% | 2.30% | 2.35% |
Inflation – RPI | 3.30% | 3.05% | 3.15% |
Inflation – CPI | 2.70% | 2.30% | 2.40% |
| 31 March | 31 March | 31 March | |
| 2026 | 2025 | 2024 | |
| Years | Years | Years | |
| Retiring today: | |||
Males | 21.9 | 21.5 | 22.1 |
Females | 23.8 | 23.7 | 24.5 |
| Retiring in 25 years: | |||
Males | 23.2 | 22.8 | 23.6 |
Females | 25.3 | 25.1 | 26.0 |
Assumption | Change in assumption | Impact on plan liabilities |
Discount rate | Increase/decrease by 0.5% | Decrease by 5.8%/increase by 5.3% |
Rate of inflation | Increase/decrease by 0.5% | Increase by 2.9%/decrease by 2.7% |
Life expectancy | Increase by one year | Increase by 2.9% |
31 March 2026 | 31 March 2025 | |||||
| UK defined | Other defined | UK defined | Other defined | |||
| benefit plans | benefit plans | Total | benefit plans | benefit plans | Total | |
| £m | £m | £m | £m | £m | £m | |
Current service cost | – | 0.4 | 0.4 | – | 0.8 | 0.8 |
Net interest credit on pension plan assets/liabilities | (0.2) | – | (0.2) | (1.5) | – | (1.5) |
(0.2) | 0.4 | 0.2 | (1.5) | 0.8 | (0.7) |
31 March 2026 | 31 March 2025 | |||||
| UK defined | Other defined | UK defined | Other defined | |||
| benefit plans | benefit plans | Total | benefit plans | benefit plans | Total | |
| £m | £m | £m | £m | £m | £m | |
Present value of defined benefit obligations | (197.0) | (10.8) | (207.8) | (199.9) | (14.6) | (214.5) |
Fair value of plan assets | 199.7 | 10.0 | 209.7 | 203.1 | 13.4 | 216.5 |
Net retirement benefit asset/(obligation) | 2.7 | (0.8) | 1.9 | 3.2 | (1.2) | 2.0 |
Plans with net retirement benefit assets | 3.0 | – | 3.0 | 4.0 | – | 4.0 |
Plans with net retirement benefit obligations | (0.3) | (0.8) | (1.1) | (0.8) | (1.2) | (2.0) |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At beginning of year | (214.5) | (247.6) |
Service cost | (0.4) | (0.8) |
Interest cost | (11.2) | (11.1) |
| Remeasurement gains/(losses): | ||
Actuarial gains arising from changes in financial assumptions | 4.4 | 25.6 |
Actuarial (losses)/gains arising from changes in demographic assumptions | (1.0) | 5.4 |
Actuarial gains arising from experience adjustments | 1.4 | 4.0 |
Contributions from plan members | (0.4) | (0.4) |
Benefits paid | 14.9 | 10.4 |
Exchange adjustments | (1.0) | – |
At end of year | (207.8) | (214.5) |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
At beginning of year | 216.5 | 278.5 |
Administration cost | (0.6) | (1.0) |
Interest income | 11.4 | 12.6 |
Actuarial losses excluding interest income | (4.8) | (65.0) |
Contributions from the sponsoring companies | 0.7 | 1.4 |
Contributions from plan members | 0.4 | 0.4 |
Benefits paid | (14.9) | (10.4) |
Exchange adjustments | 1.0 | – |
At end of year | 209.7 | 216.5 |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Defined benefit obligations | 4.8 | 35.0 |
Fair value of plan assets | (4.8) | (65.0) |
Net actuarial losses | – | (30.0) |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Cash and cash equivalent | ||
Unquoted | 4.5 | 5.0 |
| Assets held by insurance company | ||
Unquoted | 195.2 | 198.1 |
199.7 | 203.1 |
| Between | Between | Between | |||
| Less than | one and | two and | five and | ||
| one year | two years | five years | ten years | Total | |
| £m | £m | £m | £m | £m | |
| At 31 March 2026 | |||||
Halma | 9.4 | 10.8 | 32.4 | 58.6 | 111.2 |
Apollo | 1.9 | 1.9 | 5.8 | 14.8 | 24.4 |
| Year ended | |
| 31 March | |
| 2026 | |
| £m | |
Proceeds of disposal | 10.1 |
Less: net assets on disposal | (14.1) |
Less: allocation of goodwill disposed | (2.4) |
Less: costs of disposal | (2.5) |
Add: translation reserve recycled to profit and loss | 3.8 |
Loss on disposal | (5.1) |
| 31 March | |
| 2026 | |
| £m | |
| Assets classified as held for sale | |
Goodwill | 1.1 |
Other intangible assets | 6.8 |
Property, plant and equipment | 3.1 |
Deferred tax asset | 0.7 |
Inventory | 4.7 |
Trade and other receivables | 4.1 |
Tax receivable | 0.1 |
Cash and cash equivalents | 1.4 |
| 22.0 | |
| Liabilities classified as held for sale | |
Trade and other payables | (3.5) |
Lease Liabilities | (0.5) |
Provision | (0.1) |
| (4.1) |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
| Associated companies | ||
| Transactions with associated companies | ||
Sales to associated companies | 13.5 | – |
Purchases from associated companies | 0.4 | – |
| Balances with associated companies | ||
Amounts due from associated companies | 0.8 | – |
| Other related parties | ||
| Balances with other related parties | ||
Amounts due to other related parties | – | – |
Assets held by insurance company | – | – |
| Year ended | Year ended | |
| 31 March | 31 March | |
| 2026 | 2025 | |
| £m | £m | |
Wages and salaries | 15.4 | 13.7 |
Pension costs | – | – |
Share-based payment charge | 8.4 | 7.7 |
23.8 | 21.4 |